Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities

  • Filali I
  • Romdhane A
  • Znati M
  • et al.
31Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2016 Bentham Science Publishers. Harmine 1 was extracted from the seeds of Peganum harmala. From this natural molecule, a new series of isoxazole derivatives with complete regiospecificity were prepared using 1,3-dipolar cycloaddition reactions with various arylnitrile oxides. Harmine and its derivatives were characterized by 1H NMR, 13C NMR and HRMS. The evaluation of their anti-Acetylcholinesterase (AChE), anti-5-lipoxygenase (5-LOX), anti-xanthine oxidase (XOD) and anticancer activities were studied in vitro against AChE, 5-LOX and XOD enzymes, respectively, and in HTC-116, MCF7 and OVCAR-3 cancer cell lines. The prepared derivatives were shown to be inactive against the XOD enzyme (0-38.3±1.9% at 100 -M). Compound 2 exhibited the best anti-AChE activity (IC50=1.9±1.5 μM). Derivatives 3a, 3b and 3d had moderate cytotoxic activities (IC50=5.0±0.3 μM (3a) and IC50=6.3±0.4 μM (3b) against HCT 116 cells, IC50=5.0±1.0 μM (3d) against MCF7 cells).

Cite

CITATION STYLE

APA

Filali, I., Romdhane, A., Znati, M., B. Jannet, H., & Bouajila, J. (2016). Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities. Medicinal Chemistry, 12(2), 184–190. https://doi.org/10.2174/157340641202160209104115

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free